Caprock Group’s Protagonist Therapeutics PTGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
$285K Buy
5,890
+88
+2% +$4.26K 0.01% 885
2024
Q4
$224K Buy
+5,802
New +$224K 0.01% 906